Clinical application of quantitative coronary angiography using the CAAS system: preliminary results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy)
- PMID: 3049846
- DOI: 10.1007/BF01814880
Clinical application of quantitative coronary angiography using the CAAS system: preliminary results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy)
Abstract
It is the objective of the INTACT-study to test in man, whether a significant retardation of the progression of coronary artery disease is attainable with the Ca-antagonist nifedipine; this may be possible on the basis of numerous animal experiments. INTACT is a prospective, randomized, double blind, placebo controlled investigation in 423 patients with preferably early stages of coronary sclerosis in whom a progression of the disease seems likely. A proper coronary angiogram led to inclusion of the patients in the study (October 1983-June 1985). Over the following 3-years-period patients received either nifedipine 80 mg/day or placebo. The study is concluded by a control coronary angiogram with angiographic projections which are identical to those of the first coronary angiography. The extent of coronary sclerosis is objectivated by computer-assisted quantitative measurement of the entire coronary arterial system with the CAAS-system (Rotterdam). For definition purposes the coronary artery system subdivided into 25 segments. Parameters for progression assessment will be mean segment diameter, minimal obstruction diameter, percentage severity of obstruction, length of obstruction and plaque area. So far 4826 coronary segments have been analyzed from the first angiograms of 383 patients. Per patient an average of 12.6 different segments could be evaluated in at least one angiographic projection. The major coronary segments could be measured in 72-93% of the patients in one or more angiographic projections (at the average about 2 different projections). Five hundred and forty-six coronary obstructions were analyzed; 131 of these were total occlusions. Only 9% of the length of the vessel contours detected by the computer algorithm required manual correction by the operators, suggesting a high reliability of the system. It can be concluded that quantitative measurement of the complete coronary artery system can indeed be obtained in a large angiographical multicenter study such as INTACT.
Similar articles
-
International nifedipine trial on anti-atherosclerotic therapy (INTACT)--methodologic implications and results of a coronary angiographic follow-up study using computer-assisted film analysis.Int J Card Imaging. 1990-1991;6(2):117-33. doi: 10.1007/BF02398895. Int J Card Imaging. 1990. PMID: 2097305 Clinical Trial.
-
Concept of an antiatherosclerotic efficacy of calcium entry blockers. INTACT Investigators.Eur J Epidemiol. 1992 May;8 Suppl 1:107-19. doi: 10.1007/BF00145361. Eur J Epidemiol. 1992. PMID: 1505647 Review.
-
Features of the angiographic evaluation of the INTACT study. International Nifedipine Trial on Antiatherosclerotic Therapy.Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 5:1037-45. doi: 10.1007/BF02018314. Cardiovasc Drugs Ther. 1990. PMID: 2076391 Clinical Trial.
-
[Computer-assisted geometric measuring technic in coronary angiography interval studies: results of initial angiograms of the International Nifedipine Trial of Anti-atherosclerotic Therapy (INTACT) study].Z Kardiol. 1989 Jan;78(1):23-32. Z Kardiol. 1989. PMID: 2646838 Clinical Trial. German.
-
Assessment of the vasomotility of epicardial coronary arteries with quantitative coronary angiography.Z Kardiol. 1989;78 Suppl 6:143-8. Z Kardiol. 1989. PMID: 2694662 Review.
Cited by
-
International nifedipine trial on anti-atherosclerotic therapy (INTACT)--methodologic implications and results of a coronary angiographic follow-up study using computer-assisted film analysis.Int J Card Imaging. 1990-1991;6(2):117-33. doi: 10.1007/BF02398895. Int J Card Imaging. 1990. PMID: 2097305 Clinical Trial.
-
Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy).Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 5:1047-68. doi: 10.1007/BF02018315. Cardiovasc Drugs Ther. 1990. PMID: 2076392 Clinical Trial.
-
Concept of an antiatherosclerotic efficacy of calcium entry blockers. INTACT Investigators.Eur J Epidemiol. 1992 May;8 Suppl 1:107-19. doi: 10.1007/BF00145361. Eur J Epidemiol. 1992. PMID: 1505647 Review.
-
Features of the angiographic evaluation of the INTACT study. International Nifedipine Trial on Antiatherosclerotic Therapy.Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 5:1037-45. doi: 10.1007/BF02018314. Cardiovasc Drugs Ther. 1990. PMID: 2076391 Clinical Trial.
-
Clinical and angiographic variables affecting the progression of coronary artery disease as determined by quantitative angiography.Int J Card Imaging. 1994 Sep;10(3):217-25. doi: 10.1007/BF01137903. Int J Card Imaging. 1994. PMID: 7876661
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical